Targeted Therapies in Epithelial Ovarian Cancer

Molecularly targeted therapy is relatively new to ovarian cancer despite the unquestionable success with these agents in other solid tumours such as breast and colorectal cancer. Advanced ovarian cancer is chemosensitive and patients can survive several years on treatment. However chemotherapy dimin...

Descripción completa

Detalles Bibliográficos
Autores principales: Dean, Emma, El-Helw, Loaie, Hasan, Jurjees
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827593/
https://www.ncbi.nlm.nih.gov/pubmed/24281034
http://dx.doi.org/10.3390/cancers2010088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827593/
https://www.ncbi.nlm.nih.gov/pubmed/24281034
http://dx.doi.org/10.3390/cancers2010088

Ejemplares similares